Thelin (sitaxsentan): PAH drug withdrawn worldwidePfizer Canada is voluntarily withdrawing Thelin from the market worldwide due to concerns about hepatotoxicity. Lowering urate cuts cardiovascular deathsHyperuricemia deserves more aggressive treatment, researcher says Teens: Cut the salt for future health Model predicts 3 g decrease in daily intake prevents thousands of cardiovascular events Wireless feedback aids BP control Patient involvement is key to the success of telemonitoring, say Canadian researchers Hypertension family history can be misleading Quebec study shows same gene can have varying effects depending on gender Pharmacists make key contributions to primary care teams Help manage BP and other CV risk factors in diabetes patients. Breastfeeding protects moms after gestational diabetes Short-term study shows metabolic benefits in the months after pregnancy How to avoid polypharmacy in seniors Avoid woes by checking whether all pills a patient takes are needed Intense physical activity benefits type 2 patients Pharmacy BP screening lowers hospitalizations Ontario’s Cardiovascular Health Awareness Program targeted community-dwelling seniors First Previous 73 74 75 76 77 Next Last
